TYK2
MOLECULAR TARGETtyrosine kinase 2
TYK2 (tyrosine kinase 2) is targeted by 66 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TYK2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | erlotinib | 5.55 | 256 |
| 2 | imatinib | 5.47 | 236 |
| 3 | sb 203580 | 4.92 | 136 |
| 4 | tofacitinib | 4.65 | 104 |
| 5 | alvocidib | 4.52 | 91 |
| 6 | foretinib | 4.34 | 76 |
| 7 | tozasertib | 4.33 | 75 |
| 8 | ruxolitinib | 4.23 | 68 |
| 9 | pi 103 | 4.17 | 64 |
| 10 | bosutinib | 4.08 | 58 |
| 11 | midostaurin | 3.85 | 46 |
| 12 | silmitasertib | 3.78 | 43 |
| 13 | pazopanib | 3.69 | 39 |
| 14 | nintedanib | 3.61 | 36 |
| 15 | baricitinib | 3.56 | 34 |
| 16 | 6bio | 3.50 | 32 |
| 17 | tae 684 | 3.43 | 30 |
| 18 | fedratinib | 3.40 | 29 |
| 19 | dovitinib | 3.09 | 21 |
| 20 | jnj 7706621 | 3.09 | 21 |
| 21 | at 9283 | 3.09 | 21 |
| 22 | upadacitinib | 3.09 | 21 |
| 23 | lestaurtinib | 3.04 | 20 |
| 24 | pacritinib | 3.04 | 20 |
| 25 | filgotinib | 3.04 | 20 |
| 26 | momelotinib | 2.89 | 17 |
| 27 | r 406 | 2.83 | 16 |
| 28 | infigratinib | 2.77 | 15 |
| 29 | hesperadin | 2.77 | 15 |
| 30 | pha 665752 | 2.71 | 14 |
| 31 | enmd 2076 | 2.71 | 14 |
| 32 | bms 345541 | 2.71 | 14 |
| 33 | kw 2449 | 2.64 | 13 |
| 34 | ast 487 | 2.56 | 12 |
| 35 | raf 265 | 2.48 | 11 |
| 36 | defactinib | 2.48 | 11 |
| 37 | deucravacitinib | 2.48 | 11 |
| 38 | azd 1480 | 2.30 | 9 |
| 39 | reversine | 2.30 | 9 |
| 40 | su 014813 | 2.20 | 8 |
| 41 | decernotinib | 2.20 | 8 |
| 42 | gandotinib | 2.20 | 8 |
| 43 | cyc 116 | 2.08 | 7 |
| 44 | tg100 115 | 2.08 | 7 |
| 45 | cerdulatinib | 1.95 | 6 |
| 46 | itacitinib | 1.95 | 6 |
| 47 | delgocitinib | 1.95 | 6 |
| 48 | pf 03814735 | 1.79 | 5 |
| 49 | abrocitinib | 1.79 | 5 |
| 50 | Crizotinib | 1.39 | 3 |
Showing top 50 of 66 compounds. Use the BiohacksAI search to explore all TYK2 modulators.
About TYK2 as a Drug Target
TYK2 (tyrosine kinase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 66 compounds with documented TYK2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TYK2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.